Verismo, co-founded by Michael Milone, MD, PhD, Associate Professor of Pathology and Laboratory at Penn Medicine, and Donald Siegel, MD, PhD, Professor of Pathology and Laboratory Medicine at Penn Medicine, successfully manufactured its first clinical cell product using viral vector supplied by Miltenyi Bioindustry, supporting a Phase 1 clinical trial for its SynKIR™-110 for the treatment of solid tumors. Read more here.